Serum cholestanol, cholesterol precursor
β
Tatu A. Miettinend; Martti FΓ€rkkilΓ€; Matti Vuoristo; Anna-Liisa Karvonen; Rauli
π
Article
π
1995
π
John Wiley and Sons
π
English
β 837 KB
A randomized placebo-controlled 2-year study was performed in 69 patients with primary biliary cirrhosis (PBC) on serum lipids during ursodeoxycholic acid (URSO) and colchicine treatments. In addition to serum bilirubin and alkaline phosphatase (AFOS), two variables considered to reflect liver funct